Anamaria Girbovan

MD | Radiation Oncologist | Dreamer | Daughter & Sister | She/her | Tweets are mine

[eContour @eContourRadOnc]

We're looking for a senior level resident/early career faculty to join our team as an Associate Editor to help with
✅reviewing new case submissions
✅collaborating with case submitters and experts in the field

Learn more: https://t.co/QEISNP9tmm

📅Due August 15!

[NASA @NASA]

Happy 250th birthday, America! We got you a present. 🇺🇸

The red, white, and blue stars of this globular cluster shine like a sparkler waved on a dark night in this image from @NASAHubble, released in celebration of the United States' 250th anniversary.

[Shankar Siva @_ShankarSiva]

🚨 NRGGU006: prospectively validated 🎯 PAM50 = predictive 🔬 biomarker for ARPI in #ProstateCancer!

Adding apalutamide 💊 to salvage RT (no ADT) boosted 5-yr bPFS (72% vs 54%) & MFS (95% vs 82%) in luminal B tumors ➡️ no benefit in others. @DrSpratticus
#ASTRO25 #RadOnc

[Dr. Nina Niu Sanford @NiuSanford]

Comparison of toxicity w 3D v IMRT in RAPIDO: IMRT worse.

Table summarizes studies of 3D v IMRT in rectal ca – w RAPIDO, data mixed.

Caveat that RAPIDO didn’t require OAR delineation/ specify constraints, but good reminder that advanced tech doesn’t guarantee better outcomes.

[OncoAlert @OncoAlert]

WE are now mid week and what better way to get ready for #ESMOBreast25 than with Our @OncoAlert
🚨Faculty @Icro_Meattini 🇮🇹

Discussing The TOP Trials of the year in #BreastCancer Radiation Oncology☢️

Get caught up on the TOP trials and those that impacted Clinical Practice. See ALL videos On Demand 👇👇https://t.co/6ESCGkVztF

Thanking our Colloquium partners at @ESSOnews @ESGO_society @CancerCareMASCC and @SIOGorg , our collaborators and our supporters at Pfizer and Roche

@matteolambe
@aftimosp
@E_de_Azambuja
@DrSGraff
@jesusanampa
@ErikaHamilton9
@double_whammied
@stage4kelly
@coffeemommy
@maryam_lustberg
@kevinpunie
@nicolobattisti
@raalbany
@hoperugo
@stolaney1
@jamecancerdoc
@JavierCortesMD
@JaniceTNBCmets
@itrisabel
@ABCGlobalAll
@TanjaSpanic
@christeeny513
@GRASPtweets
@EuropaDonnaSLO
#OncoAlertAF
@HenningWillers
@fumikochino
@NiuSanford
@seanmmcbride

@nataliagandur
@acampsmalea
@BiagioRicciutMD
@FadiHaddad_MD
@HHorinouchi
@Dr_Ivanoncolog
@Abdallah81MD
@FernandoOnco
@ElisaAgostinett
@to_be_elizabeth
@bavilima
@realbowtiedoc
@Erman_Akkus
@Lucarecco
@GaiaGriguolo
@JankovicK

[Anamaria Girbovan @AHGirbovan]

#ESTRO25 has come to an end. Really enthusiastic being in the ESTRO25 mentoring programme ! The guidance of an experienced mentor is invaluable for young radiation oncologists, offering critical support as they develop clinical expertise and professional identity. Looking forward

[Pierre Blanchard, MD @PBlanchardMD]

STORM-PEACE V trial reported by @ZilliThomas #ESTRO25

Pelvic ENI superior to MDT for pelvic relapses after local Tx for #prostate cancer (6mo ADT each)

Improves
Biochemical PFS
Locoregional PFS
MFS
ADT free survival
Tox NS

ENI clear SOC

Online @TheLancetOncol

Cc @piet_ost

[Giulia Marvaso @GiuliaMarvaso84]

Live from #ESTRO25:
From STOMP , EXTEND to RADIOSA and 🔜 X-MET—the evidence is growing:
✅SBRT alone is good.
🌟🌟 🔥SBRT + ADT is better.
Personalized MDT strategies are here to stay.
Stronger together 💪🏻🙌.
#PCa #SBRT #MDT #XMET

[Icro Meattini @Icro_Meattini]

BCT is safe & effective for BRCA1/2 carriers—no impact on OS or DMFS

CBC risk (esp. in BRCA1) supports considering bilateral mastectomy

Personalised decisions, early BRCA testing & expert counselling are key

#ESTRO25 #BreastCancer #OncoAlert @OncoAlert @UNI_FIRENZE @AOUCareggi

[Giulio Francolini @GiulioFrancoli1]

Wonderful morning session about management of BCR in prostate cancer at ESTRO 2025. The complex shaping of a multidisciplinary issue!#ESTRO25 ,@ESTRO_RT,@piet_ost ,@Silke_Gillessen ,@ZilliThomas

[Anamaria Girbovan @AHGirbovan]

@UfferPascal @Mat_Guc @ESTRO_RT Wonderful presentation!!!

[Anamaria Girbovan @AHGirbovan]

“Primary end-point met!
The shorter, reduced dose IMRT regimen offers major advantages to patients. “
Can we start applying this into practice ? Or should we be more prudent because it is just a phase 2 trial ?

[Anamaria Girbovan @AHGirbovan]

Great presentation by @MontefioreD regarding the results of the de-escalation radiotherapy in the PLATO ACT 4 trial which have been just published today.
Phase 2 trial, T1-T2 N0/NX 2:1 reduced dose IMRT vs standard dose.

[Anamaria Girbovan @AHGirbovan]

GTV 41.4 Gy in 23 fr and CTV 34.5Gy in 23 fr vs GTV 50,4 Gy/28 fr and CTV 40 Gy in 28 fr.
Both arms associated with standard concomitent chemo MMC 12 mg/m2 Day 1 and Capecitabine 825mg/m2 BD po on RT days.

[Pierre Blanchard, MD @PBlanchardMD]

Bounce (defined as an increase > 0.2 ng/mL) following ultra hypofrac #radiotherapy, is frequent (36%) & associated with improved prognosis.

Data from HYPO RT PC at #ESTRO25

Possible bias (bounces by definition have a decrease in PSA after the rise) role of 3y landmark analysis

[Anamaria Girbovan @AHGirbovan]

Wonderful debate at #ESTRO25 between INTERLACE and KEYNOTE A18 by Cyrus Chargari, Gemma Eminowicz and Domenica Lorusso.

[Anamaria Girbovan @AHGirbovan]

Great mentoring speed dating session from the young committee at #ESTRO25
Thank you @HorsholtMorten and @DylanCallens

[Felipe Couñago PhD @fcounago]

🔥⚡️🚀Adjuvant RT after cystectomy in high-risk bladder cancer:
•25–30% LRR despite chemo
•Safe (<5% G3–4 toxicity, 3 RCTs)
•RT ↓ LRR = worthy goal

Presented by Dr. @VedangMurthy Murthy at #ESTRO2025
#BladderCancer #Radiotherapy #OncoTwitter

[Anamaria Girbovan @AHGirbovan]

4.1 years follow up of DBCG Skagen trial showed that 40Gy/ 15 does not cause > lymphedema vs 50Gy /25
The risk of LRF, DM and death not higher with 40Gy/15 vs 50Gy/25. However BCM higher using 40Gy/15, raising concerns.
BC was worse with 40Gy/15 in all subgroups tested. #ESTRO25

[Anamaria Girbovan @AHGirbovan]

Results from the 10-year efficacy and late normal tissue effects in the *FAST-Forward* randomised trial, confirm 26Gy/5Fr as appropriate SOC for breast/chest wall/ partial irradiation. presentation by Brunt Adrian Murray at #ESTRO25